La bourse est fermée

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
693,74+10,71 (+1,57 %)
À la clôture : 4:00PM EDT
Connectez-vous pour publier un message.

Tout commentaire contraire à la réglementation en vigueur (et notamment tout commentaire à caractère raciste, antisémite ou diffamatoire) pourra donner lieu à la suppression de votre compte Yahoo.

Le cas échéant, certains commentaires que vous postez pourront également donner lieu à des poursuites judiciaires à votre encontre.

  • P
    Preston
    $ZOM conversation
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation. GLTA
  • P
    Preston
    $ZOM conversation
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is %20 more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation. GLTA
  • P
    Preston
    $ZOM conversation
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.
  • D
    Da1
    $ZOM conversation
    $ZOM is going to be the rockstar of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas, BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.

    Their new CEO Robert Cohen turned 3 companies from a 0.30 cent stock to $8, and it was already predicted before his appointment that $ZOM would become an at least $3 stock.

    YESTERDAY they applied for a Trademark for MYTRUEFORMA. Paperwork is online.

    TODAY a new Truforma webpage is up on their site, also pictures of packaging, and pre-orders are being placed at the moment. PR news could drop soon and help $ZOM reach new highs. This information has yet to catch up with the rest of the market.

    Realistic bottom right now (before any news hits) is 0.68-0.70 in my opinion, and I believe if you manage to buy around that price you should expect decent profits in the Medium to Long Term.
  • P
    Preston
    $IDXX conversation
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.
  • B
    Bagholder
    $ZOM conversation
    $ZOM is going to be the rockstar of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.

    They applied for a Trademark today for MYTRUEFORMA. Like this morning January 13th that went in. Paperwork is online.

    The CEO has taken 3 previous companies from .30 to over $8 in his career. This is not his first rodeo.
  • W
    Walt
    $ZOM conversation
    $ZOM $IDXX Do I think the market will see further corrections? Most likely. Do I think ZOM will pull through regardless? Not just yes, but a RESOUNDING yes! Positive sales and new product info are going to bring us to new highs well within the year. Patience is the name of the game here people, and our new CEO knows what he is doing. We just got Miller distribution, a larger global accounting firm, and one of Zomedica's SEVERAL game changing products is finally about to release! Personally I will continue to buy any dips, and I think it's a poor time to sell. Things will rebound fast.
  • N
    N
    $ZOM conversation
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.

    The target SP by March this year is at least $10 and above.
  • N
    N
    $ZOM conversation
    *** I just came to know more about one similar device that $IDXX holds and this is 20 % less effective in diagnosis, time taken to get results, cost and portability. So, ZOMedica will surely take over the vet and pet care market with huge orders.
  • N
    N
    $ZOM conversation
    FLASH NEWS - $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX (SP @ $550) device. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.
    My target SP by March this year is at least $10 and above.
  • N
    N
    $ZOM conversation
    $ZOM is easy $10 by March device launch. The “TRUFORMA” is going to revolutionize the pets diagnostics platform. It’s competitor company is $IDXX and $ZOM is going to beat their platform for sure.
  • N
    N
    $ZOM conversation
    $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX (SP @ $550) device. Although IDXX aid a big company and serves more areas leveraging $ZOM relatively a new company has a lot of room for growth and potential increase in its SP.
  • N
    N
    $ZOM conversation
    $ZOM is going to be TESLA of pet care industry. $ZOM point of care device “TRUFORMA” is 20 times more effective and efficient than it’s competitor $IDXX device, it’s current SP is @ $550. Although IDXX is a big company and serves more areas BUT $ZOM is relatively a new company and very innovative and revolutionary so this has a lot of room for growth and potential in increasing its share price. Zomedica has around 45 patents approved on this device so that shows the innovation.

    The target SP by March this year is at least $10 and above.
  • A
    Alison
    They have a volunteer retiree from $IDXX who even bought shares with his own money... SO yeah... i’m gonna have to absolutely agree. lol ;)
  • N
    N
    $ZOM conversation
    $ZOM will one day be like $IDXX when they add more products/platforms..
  • N
    N
    $ZOM conversation
    People are selling $IDXX and buying into $ZOM, it’s competitor. “TRUFORMA” device is 20% more effective than $IDXX device
  • N
    N
    $ZOM conversation
    $ZOM new device “TRUFORMA” and it’s competitor is $IDXX. “TRUFORMA” is 20 times faster and efficient in the diagnosis of pets.
  • N
    N
    $ZOM conversation
    If $IDXX is like $TSLA then $ZOM may become like $NIO.
  • E
    Emily
    $IDXX conversation
    Five, ten and twenty day short information for $IDXX all put together https://marketwirenews.com/short-information/NASDAQ/IDXX
  • j
    jay
    $ZOM conversation
    Next #IDXX (mkt cap 44B)